RecurrenceRemission InductionTreatment OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm Recurrence, LocalPrognosisDisease-Free SurvivalFollow-Up StudiesCombined Modality TherapyTransplantation, HomologousNeoplasm, ResidualBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationSalvage TherapyLeukemia, Myeloid, AcuteBehavior, AddictiveSurvival AnalysisTime FactorsRetrospective StudiesLeukemic InfiltrationGraft vs Host DiseaseTransplantation, AutologousSurvival RateCyclophosphamideVincristineMethotrexateMultiple Sclerosis, Relapsing-RemittingCytarabineSelf AdministrationCocaine-Related DisordersPrednisoneHodgkin DiseaseTransplantation ConditioningProspective StudiesLeukemiaAsparaginaseTemperanceTreatment FailureSubstance Withdrawal SyndromeTesticular NeoplasmsExtinction, PsychologicalPrimaquineNeoplasm StagingDrug-Seeking BehaviorAcute DiseaseRemission, SpontaneousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Administration ScheduleLeukemia, LymphoidCentral Nervous System NeoplasmsActuarial AnalysisBone MarrowPrecursor B-Cell Lymphoblastic Leukemia-LymphomaSmoking CessationEtoposideLeukemia, MyeloidLymphoma, Non-HodgkinAntineoplastic AgentsAlcoholismRisk FactorsPrednisoloneMultiple Sclerosis6-MercaptopurineHematologic NeoplasmsDrug Therapy, CombinationLeukemia, Promyelocytic, AcuteTumor Markers, BiologicalCocaineBreast NeoplasmsImmunosuppressive AgentsGraft vs Leukemia EffectKaplan-Meier EstimateLeukocyte TransfusionDisease ProgressionConditioning, OperantPredictive Value of TestsWegener GranulomatosisMalaria, VivaxLife TablesClinical Trials as TopicCuesDoxorubicinAntibodies, Antineutrophil CytoplasmicNephrotic SyndromeWhole-Body IrradiationBone Marrow PurgingIdarubicinMultiple MyelomaChemotherapy, AdjuvantAntibodies, Monoclonal, Murine-DerivedDouble-Blind MethodVasculitisProportional Hazards ModelsCohort StudiesDrug Resistance, NeoplasmMultivariate AnalysisNephrosis, LipoidDaunorubicinCranial Irradiation